---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-109807"
form_type: "8-K"
ticker: "KPRX"
cik: "0001372514"
company_name: "KIORA PHARMACEUTICALS INC"
filed_at: "2021-08-26T23:59:59+00:00"
generated_at: "2026-06-29T07:30:52.617747+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# EyeGate VP Engineering Michael Manzo departs as of Aug 20, 2021

## Summary
- Michael Manzo ceased serving as VP of Engineering effective August 20, 2021.
- No replacement has been announced; remaining executive team unchanged.
- Departure follows customary transition; no reason provided in filing.

## SEC filing metadata
- accession: 0001104659-21-109807
- form_type: 8-K
- ticker: KPRX
- cik: 0001372514
- company_name: KIORA PHARMACEUTICALS INC
- filed_at: 2021-08-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372514/000110465921109807/0001104659-21-109807-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372514/000110465921109807/tm2117495d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-109807
- JSON: https://secwatch.observer/filing/0001104659-21-109807.json
- Plain text: https://secwatch.observer/filing/0001104659-21-109807.txt

## Key facts
- Executive change
  Michael Manzo departed as Vice President of Engineering at KIORA PHARMACEUTICALS INC.
  - Action: ceased serving
  - Role: Vice President of Engineering
  source text: Effective as of August 20, 2021, Michael Manzo ceased serving as the Vice President of Engineering of EyeGate Pharmaceuticals, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1372514/000110465921109807/0001104659-21-109807-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.